Parametric Portfolio Associates’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$12.2M Buy
339,347
+174,951
+106% +$6.28M 0.01% 1240
2021
Q4
$3.83M Buy
164,396
+13,608
+9% +$317K ﹤0.01% 2044
2021
Q3
$2.87M Sell
150,788
-1,242
-0.8% -$23.6K ﹤0.01% 2191
2021
Q2
$3.07M Buy
152,030
+41,544
+38% +$838K ﹤0.01% 2173
2021
Q1
$2.02M Buy
110,486
+10,027
+10% +$184K ﹤0.01% 2772
2020
Q4
$2.02M Sell
100,459
-16,509
-14% -$332K ﹤0.01% 2644
2020
Q3
$2.19M Buy
116,968
+2,588
+2% +$48.5K ﹤0.01% 2459
2020
Q2
$2.57M Buy
114,380
+28,411
+33% +$638K ﹤0.01% 2343
2020
Q1
$1.28M Sell
85,969
-33,637
-28% -$499K ﹤0.01% 2657
2019
Q4
$2.31M Sell
119,606
-37,042
-24% -$714K ﹤0.01% 2599
2019
Q3
$3.11M Sell
156,648
-15,008
-9% -$298K ﹤0.01% 2370
2019
Q2
$3.62M Buy
171,656
+14,324
+9% +$302K ﹤0.01% 2240
2019
Q1
$3.21M Sell
157,332
-46,495
-23% -$950K ﹤0.01% 2318
2018
Q4
$4.06M Buy
203,827
+88,021
+76% +$1.75M ﹤0.01% 2058
2018
Q3
$2.23M Buy
115,806
+54,014
+87% +$1.04M ﹤0.01% 2641
2018
Q2
$943K Sell
61,792
-13,340
-18% -$204K ﹤0.01% 3088
2018
Q1
$1.41M Buy
75,132
+3,950
+6% +$74.1K ﹤0.01% 2824
2017
Q4
$1.37M Buy
71,182
+22,391
+46% +$431K ﹤0.01% 2847
2017
Q3
$872K Buy
48,791
+3,176
+7% +$56.8K ﹤0.01% 3110
2017
Q2
$815K Buy
45,615
+19,091
+72% +$341K ﹤0.01% 3093
2017
Q1
$385K Sell
26,524
-37,621
-59% -$546K ﹤0.01% 3327
2016
Q4
$1.18M Buy
64,145
+1,912
+3% +$35.2K ﹤0.01% 2729
2016
Q3
$1.18M Buy
62,233
+4,888
+9% +$92.8K ﹤0.01% 2704
2016
Q2
$924K Buy
57,345
+10,576
+23% +$170K ﹤0.01% 2877
2016
Q1
$561K Buy
46,769
+4,731
+11% +$56.7K ﹤0.01% 3269
2015
Q4
$598K Buy
42,038
+26,029
+163% +$370K ﹤0.01% 3132
2015
Q3
$187K Buy
+16,009
New +$187K ﹤0.01% 3103